Latest news
BioMarin Pharmaceutical Inc. (BMRN) Stock Forecasts - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 09:15:18 GMTBioMarin: Amicus Integration Targets $280 Million Of Cost Cuts As Acquired Therapies Aim For 60%+ Operating Margin - Pulse 2.0Pulse 2.0 · Sat, 08 Aug 2026 02:37:10 GMTBioMarin (BMRN) Stock Gains On Higher Outlook Despite Profit Drop - simplywall.stsimplywall.st · Fri, 07 Aug 2026 23:19:07 GMTMorgan Stanley Issues Positive Forecast for BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price - MarketBeatMarketBeat · Fri, 07 Aug 2026 19:21:21 GMTBioMarin bins rare disease asset from Inozyme acquisition - FirstWord PharmaFirstWord Pharma · Fri, 07 Aug 2026 18:42:10 GMTBioMarin Pharmaceutical Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:BMRN) 2026-08-07 - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 17:05:22 GMTBioMarin drops BMN 401 following unsuccessful pivotal trial - AllSciAllSci · Fri, 07 Aug 2026 16:01:43 GMTBioMarin Lifts 2026 Outlook on Strong Voxzogo Sales, Wedbush Says - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 15:44:27 GMT